Algert Global LLC Acquires New Stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO)
MarketBeat
Algert Global LLC acquired a new stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 10,900 shares of the biopharmaceutical company's stock, valued
NASDAQ:HALO